
BioXcel Therapeutics Investor Relations Material
Latest events

Q3 2024
BioXcel Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from BioXcel Therapeutics Inc
Access all reports
BioXcel Therapeutics, Inc. is a biopharmaceutical company focused on utilizing artificial intelligence to discover and develop new therapies in neuroscience and immuno-oncology. The company leverages its proprietary AI platform to identify and advance drug candidates for the treatment of complex conditions, including psychiatric disorders and cancers. BioXcel Therapeutics is engaged in both clinical and preclinical development. The company is headquartered in New Haven, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
BTAI
Country
🇺🇸 United States